Vivos (RDGL) Invested Capital (2011 - 2023)

Vivos (RDGL) posted Invested Capital of $10000.0 for Q3 2023, down 75.0% sequentially from $40000.0 in Q1 2018.

Vivos (RDGL) Invested Capital (2011 - 2023) Analysis & Trends

Vivos has reported Invested Capital for 9 years, with the latest figure at $10000.0 in Q3 2023.

Quarterly Invested Capital changed N/A year-over-year to $10000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $10000.0 (changed N/A YoY) and the FY2016 annual result came in at $332195.0, down 74.06% from the prior year.
Invested Capital fell to $10000.0 in Q3 2023 per RDGL's latest filing, from $40000.0 in the prior quarter.
Over five years, Invested Capital peaked at $10000.0 in Q3 2023 and troughed at $10000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	3.01 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	750.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	1.34 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	243.40 Mn
10	Vivos	22.64 Mn	21.08 Mn	-3,105.00	-

Download Data